Retatrutide (LY3437943) Research Peptide

Free Priority Shipping on Orders $99+

Retatrutide (LY3437943) research vials for qualified laboratory use. Select a currently available vial size and formulation. The selected variation label and matching lot documents control formulation, measured content, purity, and reported tests. A Standard vial must not be assumed to be Mannitol-Free. Not for human or veterinary use.

From $120.00

Lot-Specific Analytical Records

Results Reported for the Identified Lot

Each result applies to the sample and lot identified in the report. Open the COA for the methods, analytes, and limits reported.
10mg
Reported content: 11.20 mg
Purity: 99.87%
Endotoxin result: Pass
Microbial result: Pass
Lot #062503
12mg
Reported content: 13.75 mg
Purity: 99.50%
Lot #062503
15mg
Reported content: 14.91 mg
Purity: 99.81%
Endotoxin result: Pass
Lot #062503
20mg
Reported content: 22.69 mg
Purity: 99.81%
Endotoxin result: Pass
Microbial result: Pass
Lot #062503
30mg
Reported content: 29.84 mg
Purity: 99.98%
Endotoxin result: Pass
Lot #062503
50mg
Reported content: 54.13 mg
Purity: 99.87%
Endotoxin result: Pass
Microbial result: Pass
Lot #062504
View Prior Batch Reports (10)
Open each COA to see the issuing laboratory, methods, and reported results.

Retatrutide research vials

BulkGLP supplies lyophilized Retatrutide (LY3437943) research vials in the sizes and formulations shown in the variation selector. Standard and Mannitol-Free are distinct configurations. Verify the selected variation, product label, and matching lot documents before use.

Variation and lot documentation

  • Vial format: Select from the sizes currently shown on this page
  • Standard formulation: Composition and excipients must be stated on the selected variation label or batch record
  • Mannitol-Free formulation: Applies only when the selected variation and matching batch record explicitly say Mannitol-Free
  • Purity and measured content: See the report for the exact lot and variation supplied
  • Other tests: Results apply only to the identified sample and analytes named in the report
  • Packs: Confirm that the pack and each unit map to the stated lot documentation

No page-wide purity threshold, additive-free statement, or formulation claim applies across every variation.

What is Retatrutide (LY3437943)?

Retatrutide is an investigational peptide agonist at the GLP-1, GIP, and glucagon receptors. Published primary studies describe it as a triple-hormone-receptor agonist. There is no recognized “GLP-3 receptor.” This product is supplied only as a laboratory research material and is not approved for human or veterinary use.

Product specifications

  • Name: Retatrutide
  • Development identifier: LY3437943
  • Receptor description: GLP-1, GIP, and glucagon receptor agonist
  • Nominal vial content: Selected variation; confirm against the product label and lot documents
  • Purity: See the matching active-lot analytical report
  • Formulation and additives: Variation-specific; see the selected variation label and batch record
  • Intended use: In-vitro or ex-vivo laboratory research only

Primary literature

Weight 0.1 lbs
Dimensions 2 × 2 × 2 in
Size

5mg, 10mg, 12mg, 15mg, 20mg, 30mg, 50mg, 5mg – 10 Pack, 10mg – 10 Pack, 15mg – 10 Pack, 20mg – 10 Pack, 30mg – 10 Pack

Formulation

Standard (Default), Mannitol Free

Get 10% Off Your Order!

Join our list and get an instant discount code.

You're In!

Use this code at checkout:

Get 10% Off
Get 10% Off
0